E2ES to Accelerate Next-Generation Genome Analysis in Clinical Research
|
|
- Barnard Dickerson
- 6 years ago
- Views:
Transcription
1 E2ES to Accelerate Next-Generation Genome Analysis in Clinical Research whitepaper April 2015
2 TABLE OF CONTENTS Introduction 3 Challenges associated with NGS data analysis 3 HCL s NGS Solution for Data Analysis 4 HCL s NGS Solution for Integration 5 Benefits 5 Conclusion 6 References 6 authors , HCL Technologies. Reproduction Prohibited. This document is protected under Copyright by the Author, all rights reserved. 2
3 Introduction The science of genomics is at the beginning of a new era of innovation. Today, a human genome can be sequenced in a few hours and for a few thousand dollars; a task that took 13 years and USD 2.7 billion to accomplish during the Human Genome Project. Next Generation Sequencing (NGS) has revolutionized the way we carry out biological research today. The applications of NGS seem endless; various applications of the technology in the fields of science such as cancer research, disease diagnosis, biofuels, marine sciences, livestock research, agricultural, and veterinary research drive the NGS market. Another important driver of the sector is to provide cheaper sequencing possibilities for needing patients in the provider universe. Advances in the next-generation sequencing technology have opened the door to leveraging genomics in personalized medicine and clinical trials. Still, the clinical research is mostly based on enrolling clinically similar participants to evaluate the efficacy and safety of new drugs. In many trials selection criteria based on genotypic standards are still unavailable. Performing clinical trials on such patient populations carries the risk of exposure to relatively smaller population and any statistically significant treatment benefit may occur in only a small proportion of patients. The inadequacy in clinical trial procedure leads to the drug being considered as a failure despite providing real benefit for some patients. Next generation genomics has the potential to transform how doctors diagnose and treat cancer as well as other diseases. According to McKinsey report, the economic impact of next-generation gene sequencing in health care, agriculture, and the production of substances such as biofuels could be USD 700 billion to USD 1.6 trillion a year by About 80 percent of this potential value would be realized through extending and enhancing lives through faster disease detection, more precise diagnoses, newer drugs, and more tailored disease treatments. 26 million annual deaths take place from cancer, cardiovascular disease or Type 2 diabetes, and the global health-care cost is USD 6.5 trillion. The paper discusses on how IT can enable NGS as its space gets bigger and bigger. Challenges associated with NGS data analysis Over the past decade, the improvement value in sequencing speed has exceeded Moore s law. The improvement in gene sequencing performance has been achieved by creating highly parallel systems that can sequence millions of DNA base pairs in a very short time. The major challenges of NGS technology are as follows: y The growth of technology has rapidly generated massive data and posed a fundamental problem of data management, workflow, and analysis. Data analysis is time consuming and may require special knowledge of bioinformatics to garner accurate information from sequence data. 2015, HCL Technologies. Reproduction Prohibited. This document is protected under Copyright by the Author, all rights reserved. 3
4 y NGS technology mandates extensive investments in networking speed, data storage facilities, and high-performance computing capability through hardware and software platforms. These platforms acquire, store, and analyze large datasets created by these instruments. y Data integration and Business Intelligence to retrieve, analyze, and integrate NGS data with patients /clinical trial participants data. The next-generation gene sequencing depends on improvements in computational power and big data analytics capability. HCL s NGS Solution for Data Analysis Analyzing NGS data is a challenging and time-consuming operation for scientists. Considering the pain points of data analysis and the challenges associated with them, HCL along with its partners proposes a Graphical Workflow Environment framework, which can automate the required set of workflows for NGS applications to populate analysis data. It has the following features and process: y A built-in data management system allows the import of large sequence data files directly from the sequencing instrument pipeline. This system also helps in cataloguing and storing these files for subsequent use. y Software specialized for next-generation sequence alignment and post-processing includes: 1. Align read 2. De novo assembly 3. Quality control 4. Single nucleotide polymorphism 5. Indels 6. Copy number variation 7. Annotation y It is more flexible for users to modify the workflow and develop any additional steps interfacing with other computational tools. y The output of each component is interlinked with the subsequent process to create graphical workflow pipelines. Several alternative workflows can run independently or get connected in a logical flow. 2015, HCL Technologies. Reproduction Prohibited. This document is protected under Copyright by the Author, all rights reserved. 4
5 HCL s NGS Solution for Integration Ability to integrate and mine public and proprietary datasets from microarray and next-gen technologies is central to present-day biology. HCL and its partners have developed a Big Data analytics and BI solution for NGS data with the following features: y Tight integration of the participant s genomics data with clinical trial data and pathway information. y Clinical trial participants can be segmented based on genomic profiles. y Gene expression signature can be predicted based on pharmacogenomics activity. y Disease subtype or progression stages can be analyzed based on genomics data. y Prediction of new complex genetic signature by accessing literature and public database. Researcher/Clinical Convert the Sample data and meta data into Sample Sheet Receive input from customer Genomic Core Facility Interface for Data Entry L I M S Report Sequencing details and Workflow management using LIMS Data warehouse Cloud Services Sequence Align Analyzed using Indels Pipelines SNP CNV Annotation * Integration of Omics data with Patient data * BI Analysis HPC Environment 1 Benefits y Automatic analysis pipeline helps reduce analysis time. The reduction in time removes manual data transfer at every step, rendering data preparation to be painless and simple for implementation, analysis, and storage. y Rational selection of patients for clinical trials based on their predicted sensitivity to the drug will increase the response rates, shorten the duration and cut the cost of the clinical drug development. y Observed therapeutic response helps discover potential biomarkers, develop diagnostic assays and higher the potential for drug efficacy with fewer adverse events. 2015, HCL Technologies. Reproduction Prohibited. This document is protected under Copyright by the Author, all rights reserved. 5
6 Conclusion NGS has numerous opportunities to be explored and leveraged in many fields, and it has its own set of challenges. One of the major challenges is the preparation of data that can be addressed by having the HCL-proposed Graphical Workflow Environment. If leveraged during clinical trials, NGS will improve patient selection, translate base pair reads to bedside applications, and better the understanding of disease condition itself. The most pressing challenge to NGS technologies is the need to expedite the use of NGS data in the clinical practice of medicine. Analysis of large sequencing datasets mandates an advanced computational infrastructure dedicated to preserving, processing, and analyzing NGS data. HCL has associated with a partner to provide High Performance Computing services for NGS analysis and develop its capability in data analysis and data integration to facilitate clinical action. References 1. McKinsey on Personalized Medicine, March Disruptive technologies: Advances that will transform life, business and the global company. McKinsey Global Institute May Bioinformatics Market By Sector (Molecular Medicine, Agriculture, Research & Forensic), Segment (Sequencing Platforms, Knowledge Management Tools & Data Analysis Services) & Application (Genomics, Proteomics & Drug Design) Global Forecasts to 2017, MarketsandMarkets, Next Generation Sequencing (NGS) Market [Platforms (Illumina HiSeq, MiSeq, Life Technologies Ion Proton/PGM, 454 Roche), Bioinformatics (RNA-Seq, ChIP-Seq), (Pyrosequencing, SBS, SMRT), (Diagnostics, Personalized Medicine)] Global Forecast to 2017, MarketsandMarkets, , HCL Technologies. Reproduction Prohibited. This document is protected under Copyright by the Author, all rights reserved. 6
7 HCL LIFE SCIENCES & HEALTHCARE HCL is a leading provider of Life Sciences and Healthcare Business and Technology services. We are the chosen service provider for enabling new growth drivers for our clients, providing them with industry leading best practices, taking care of their compliance needs and ensuring goldstandard process cycle times. Our clientele includes seven of the top ten global pharmaceutical companies, seven of the top ten medical devices companies, six of the top ten health plans, three of the top five CRO s and two of the top three data providers. Equipped with certified technology experts and domain specialists, HCL offers services in critical areas of the life sciences and healthcare eco system such as drug discovery, clinical development, drug safety, regulatory compliance, manufacturing and plant automation, commercial, Healthcare analytics, Population Health Management [PHM], mhealth, member experience management [MEM], fraud, waste and abuse management [FWA]. Let s connect Please feel free to write to us at contact.lsh@hcl.com authors Dr. OmPraba joined HCL s family in August She is a trained and certified professional of Veeva Vault Admin, Accelrys Insight II, and Cerius2 products. She has an extensive knowledge and hands-on experience in operating various applications used in drug design and development. She has published 10 papers in reputed national and international journals and has given oral presentations in international conferences. She is currently working as a lead consultant with Life Science Vertical at HCL technologies. As a business analyst and a domain consultant, she has been involved in various development projects for leading pharmaceutical clients in the pharmaceutical R&D space. She is a part of HCL Training Academy and an SME for pharmaceutical business process trainings for various accounts at HCL. She has a doctorate degree in the field of Biochemistry and Biophysics from the University of Madras. She has an extensive research experience in the field of computer-aided drug design, molecular modeling, molecular biology/biotechnology and crystallography. 2015, HCL Technologies. Reproduction Prohibited. This document is protected under Copyright by the Author, all rights reserved. 7
8 About HCL About HCL Technologies HCL Technologies is a leading global IT services company working with clients in the areas that impact and redefine the core of their businesses. Since its emergence on the global landscape, and after its IPO in 1999, HCL has focused on transformational outsourcing, underlined by innovation and value creation, offering an integrated portfolio of services including software-led IT solutions, remote infrastructure management, engineering and R&D services and business services. HCL leverages its extensive global offshore infrastructure and network of offices in 31 countries to provide holistic, multi-service delivery in key industry verticals including Financial Services, Manufacturing, Consumer Services, Public Services and Healthcare & Life sciences. HCL takes pride in its philosophy of Employees First, Customers Second which empowers its 104,184 transformers to create real value for customers. HCL Technologies, along with its subsidiaries, had consolidated revenues of US$ 5.8 billion, for the Financial Year ended as on 31st March 2015 (on LTM basis). For more information, please visit About HCL Enterprise HCL is a $6.9 billion leading global technology and IT enterprise comprising two companies listed in India HCL Technologies and HCL Infosystems. Founded in 1976, HCL is one of India s original IT garage start-ups. A pioneer of modern computing, HCL is a global transformational enterprise today. Its range of offerings includes product engineering, custom & package applications, BPO, IT infrastructure services, IT hardware, systems integration, and distribution of information and communications technology (ICT) products across a wide range of focused industry verticals. The HCL team consists of over 109,643 professionals of diverse nationalities, who operate from 31 countries including over 505 points of presence in India. HCL has partnerships with several leading global 1000 firms, including leading IT and technology firms. For more information, please visit Hello there! I am an Ideapreneur. I believe that sustainable business outcomes are driven by relationships nurtured through values like trust, transparency and flexibility. I respect the contract, but believe in going beyond through collaboration, applied innovation and new generation partnership models that put your interest above everything else. Right now 109,000 Ideapreneurs are in a Relationship Beyond the Contract with 500 customers in 31 countries. How can I help you?
<theme image> Big Data - PD1 big data by Shantanu Baruah
www.hcltech.com Big Data - PD1 big data by Shantanu Baruah WHITEPAPER SEPTEMBER 2014 TABLE OF CONTENTS BIG DATA OPPORTUNITIES EVOLVING IN LIFE SCIENCES 3 PD1 THERAPIES ACCELERATOR 3 ENGAGEMENT
More informationThe Way to Patient Centricity - Through Mobility and Social Media
The Way to Patient Centricity - Through Mobility and Social Media AuthOr: Abhishek Verma Healthcare Business Solutions Group KODESWARAN P. Healthcare Business Solutions Group WHITEPAPER January 2016 TABLE
More informationIn-Process Automation
www.hcltech.com In-Process Automation business assurance & testing Author: Sajitha Radhakrishnan SL CORE APPS-TESTING-TESTING-FT-BFSI HCL Technologies Ltd., Bangalore, India Sajitha.R@hcl.com WHITEPAPER
More informationSolving key business challenges with a Big Data Lake
www.hcltech.com Solving key business challenges with a Big Data Lake big data & business analytics AuthOr: john wills global director, center of excellence hcl business analytics services WHITEPAPER AUGUST
More informationLearn the 5 keys to moving to a successful data-as-a-service model
www.hcltech.com Learn the 5 keys to moving to a successful data-as-a-service model big data & business analytics AuthOr: john wills global director, center of excellence hcl business analytics services
More informationambiguous insights through HCL s R&D Transformation limit your business
ambiguous insights through HCL s R&D Transformation limit your business Life Sciences industry is undergoing a transformational change - blockbuster patent expirations, global interconnected world, and
More informationWHITE PAPER COLLABORATING WITH DIGITAL AGENCIES USING A SHARED TECHNOLOGY PLATFORM
COLLABORATING WITH DIGITAL AGENCIES USING A SHARED TECHNOLOGY PLATFORM Are you struggling to coordinate with digital agencies and technology service providers for the execution of your digital initiatives?
More informationGOAL-BASED CUSTOMER REPORTING ADIVISORY AND WEALTH MANAGEMENT
www.hcltech.com GOAL-BASED CUSTOMER REPORTING ADIVISORY AND WEALTH MANAGEMENT WHITEPAPER OCtober 2014 TABLE OF CONTENTS GOAL-BASED CUSTOMER REPORTING ABOUT HCL EVOLUTION TRENDING CONSTITUENTS OF A GOOD
More informationIndustrialized Clinical Data Standards Management Speed of automation, Power of accuracy and Transforming clinical data into business intelligence
Industrialized Clinical Standards Management Speed of automation, Power of accuracy and Transforming clinical data into business intelligence Executive Summary The majority of commercially available legacy
More informationWhite paper. Member Lifetime Value in Health Plans - Factors & Calculation. RAVI SANKAR C J Head, Healthcare Solutions
Member Lifetime Value in Health Plans - Factors & Calculation RAVI SANKAR C J Head, Healthcare Solutions SAURABH GAUR Business Manager, Healthcare Solutions White paper April 2013 Copyright Notice This
More informationNuances of Low Cost Effective LIMS Implementation: Can SaaS be an option?
February 2010 Nuances of Low Cost Effective LIMS Implementation: Can SaaS be an option? By Padmanabhan Nagalingam Contents Abstract 2 What is LIMS? 3 What is Cloud Computing? 3 LIMS through Cloud Computing
More informationHCL PLM Upgrade Framework
HCL PLM Upgrade Framework M a r c h 2011 TABLE OF CONTENTS Abbreviations... 3 PLM Upgrade Framework... 4 Author Info... 8 Abbreviations Sl. No. Acronyms Full form 1 PLM Product Lifecycle Management 2 DB
More informationFebruary HIPAA 5010 Systems Impacts
February 2010 HIPAA 5010 Systems Impacts Current Scenario The Center for Medicaid and Medicare Services (CMS) requires the health plans to adopt modifications to the HIPAA electronic transaction standards
More informationManage technological disruptiveness, Leverage HCL s Public Services to get greater value
Manage technological disruptiveness, Leverage HCL s Public Services to get greater value Public Services practice at HCL HCL Technologies a USD 6.5 billion global company brings IT and engineering services
More informationMarch Harmonization of Standards for Better Regulatory Compliance
March 2010 Harmonization of Standards for Better Regulatory Compliance Contents Abstract 2 High Level Interpretation of USP 3 High Level Interpretation of ASTM E2500 07 4 Aligning ASTM E2500 concepts
More informationManage technological disruptiveness, Leverage HCL s Public Services to get greater value
Manage technological disruptiveness, Leverage HCL s Public Services to get greater value Public Services practice at HCL HCL Technologies a USD 6.5 billion global company brings IT and engineering services
More informationMeasuring Promotion Effectiveness in Times of Increased Consumer Spending WHITE PAPER
Measuring Promotion Effectiveness in Times of Increased Consumer Spending WHITE PAPER OCTOBER 2013 TABLE OF CONTENTS DEFINING PROMOTION EFFECTIVENESS 3 GLOBAL PERSPECTIVE ON CONSUMER SPENDING DURING PROMOTIONAL
More informationCustomer Experience Solutions: Mobility & Social Media
Customer Experience Solutions: Mobility & Social Media Author: Ashwin Kumar Subramanian, Manager, Healthcare BSG whitepaper dec 2011 With reforms led changes, a new healthcare system is emerging in the
More informationA New Approach to Regulatory Compliance
www.hcltech.com A New Approach to Regulatory Compliance David Paris Global Solutions Partner - Risk, Compliance and Data HCL Technologies TABLE OF CONTENTS A FRAMEWORK FOR REGULATORY REPORTING FACTORY
More informationFebruary Multiple Repositories... What is your Best Strategy?
February 2010 Multiple Repositories... What is your Best Strategy? Contents Introduction 2 The Problem 3 The Strategies Available 3 Content Consolidation 4 Content Federation 4 The Vicious Cycle 5 How
More informationShivom, the global Genomics-Blockchain Ecosystem The Next Era of Genomics and Healthcare
Shivom, the global Genomics-Blockchain Ecosystem The Next Era of Genomics and Healthcare The world of healthcare is changing - with two revolutionary technologies, genomics and blockchain poised to significantly
More informationFRACA 1 (Failure Reporting and Corrective Action)
FRACA 1 (Failure Reporting and Corrective Action) O c t o b e r 2011 TABLE OF CONTENTS Abstract... 3 Abbreviations... 4 Market Need... 5 Solution... 6 Best Practices... 8 Common Issues... 10 Conclusion...
More informationHCL s HITRUST SOLUTION Redefining Healthcare Security Compliance
www.hcltech.com HCL s HITRUST SOLUTION Redefining Healthcare Security Compliance How can HCL help with your HITRUST initiatives? Why is HITRUST important? Healthcare faces a wide variety of data privacy
More informationIntroduction to Bioinformatics
Introduction to Bioinformatics Richard Corbett Canada s Michael Smith Genome Sciences Centre Vancouver, British Columbia June 28, 2017 Our mandate is to advance knowledge about cancer and other diseases
More informationSIMULATION OF GASKET LEAKAGE AND CO-RELATION TO DESIGN
SIMULATION OF GASKET LEAKAGE AND CO-RELATION TO DESIGN S e p t e m b e r 2011 TABLE OF CONTENTS Abstract... 3 Abbreviations... 4 Problem Description... 5 Product Construction... 6 Product Assembly... 7
More informationEnabling your EPM building blocks for a Digital Finance journey
WWW.HCLTECH.COM Enabling your EPM building blocks for a Digital Finance journey In most leading corporations, the Office of CFO and Finance IT systems have embarked on a multi-faceted transformation journey
More informationPAREXEL GENOMIC MEDICINE SERVICES. Applying genomics to enhance your drug development journey
PAREXEL GENOMIC MEDICINE SERVICES Applying genomics to enhance your drug development journey YOUR JOURNEY. OUR MISSION. Genomic expertise to simplify the route to product approval and maximize patient
More informationPLM Mobility. Author Karthikeyan WHITE PAPER
PLM Mobility Author Karthikeyan WHITE PAPER June 2012 TABLE OF CONTENTS Abbreviations 3 Introduction 4 Mobility Trends 4 Challenges on Mobility for a Manufacturing Company 5 Mobility for Manufacturing:
More informationM a x i m i z in g Value from NGS Analytics in t h e E n terprise
Global Headquarters: 5 Speen Street Framingham, MA 01701 USA P.508.935.4445 F.508.988.7881 www.idc-hi.com M a x i m i z in g Value from NGS Analytics in t h e E n terprise C U S T O M I N D U S T R Y B
More informationIntroducing a Highly Integrated Approach to Translational Research: Biomarker Data Management, Data Integration, and Collaboration
Introducing a Highly Integrated Approach to Translational Research: Biomarker Data Management, Data Integration, and Collaboration 1 2 Translational Informatics Overview Precision s suite of services is
More informationTABLE OF CONTENTS. Executive Summary 3. Retail Stores Management 4 Trends, Business and Operational Challenges
FEBRUARY 2013 TABLE OF CONTENTS Executive Summary 3 Retail Stores Management 4 Trends, Business and Operational Challenges Applying the Right Technology solutions 8 for Next Gen Stores Management A Fully
More informationSmarter Healthcare across the Lifecycle with Analytics
Smarter Healthcare across the Lifecycle with Sponsored by IBM Srini Chari, Ph.D., MBA August 2018 mailto:info@cabotpartners.com Executive Summary Healthcare is rapidly evolving from volume-based care to
More informationGenomics Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research
Genomics Market Share, Size, Analysis, Growth, Trends and Forecasts to 2024 Hexa Research " Increasing usage of novel genomics techniques and tools, evaluation of their benefit to patient outcome and focusing
More informationA New Approach in Control Valve Design With a New Hybrid Flow Characteristic
A New Approach in Control Valve Design With a New Hybrid Flow Characteristic Dr. R.S. Madhusudan, ERS Mechanical Team, HCL Bangalore F e b r u a r y 2012 TABLE OF CONTENTS Abstract... 3 Abbreviations...
More informationEMPOWERING THE NEW HEALTHCARE ECOSYSTEM
EMPOWERING THE NEW HEALTHCARE ECOSYSTEM 2 Today, the healthcare industry finds itself on the threshold of a new era in which key stakeholders, empowered by technology, are breaking down barriers and redefining
More informationBayer Pharma s High Tech Platform integrates technology experts worldwide establishing one of the leading drug discovery research platforms
Bayer Pharma s High Tech Platform integrates technology experts worldwide establishing one of the leading drug discovery research platforms Genomics Bioinformatics HTS Combinatorial chemistry Protein drugs
More informationDATA INSIGHTS TO POWER YOUR DIGITAL TRANSFORMATION JOURNEY
DATA INSIGHTS TO POWER YOUR DIGITAL TRANSFORMATION JOURNEY RIGHT DATA & RELEVANT DATA HCL@THINK 2018 ANNUAL IBM CONFERENCE Right Data & Relevant Data (R2D2) Building Data Assets across the Digital Enterprise
More informationPowered by. IoT STRATEGY : INSIGHTS FROM EARLY IoT ADOPTERS
Powered by IoT STRATEGY : INSIGHTS FROM EARLY IoT ADOPTERS 2 GLOBAL IoT REPORT 2017 Executive Summary Technology and trends come and go, but IoT has what it takes to transform organizations and shape the
More informationGenomic solutions for complex disease
Genomic solutions for complex disease Power your with our genomic solutions Access a breadth of applications. Gain a depth of insights. To enhance their understanding of complex disease, researchers are
More informationVisit our Career Flowchart to get more information on some of these career paths.
Visit our Career Flowchart to get more information on some of these career paths. Academic Research Faculty: This career path consists of university or college professors who conduct research. They select
More informationDNA. Clinical Trials. Research RNA. Custom. Reports CLIA CAP GCP. Tumor Genomic Profiling Services for Clinical Trials
Tumor Genomic Profiling Services for Clinical Trials Custom Reports DNA RNA Focused Gene Sets Clinical Trials Accuracy and Content Enhanced NGS Sequencing Extended Panel, Exomes, Transcriptomes Research
More informationCCTG initiative. patient reported outcomes (including wearables)
Executive Summary Canada can be a global leader in the next generation of pharmaceutical and cancer care innovation. The Canadian Cancer Trials Group (CCTG) is requesting $39 million in federal funding
More informationLife Sciences Debashis Ghosh. 1 Copyright 2016 Tata Consultancy Services Limited
Life Sciences Debashis Ghosh 1 Copyright 2016 Tata Consultancy Services Limited From biology, chemistry and anatomy to data, analytics and technology Analytics driven Genomics Research We identify disease
More informationPioneering Clinical Omics
Pioneering Clinical Omics Clinical Genomics Strand NGS An analysis tool for data generated by cutting-edge Next Generation Sequencing(NGS) instruments. Strand NGS enables read alignment and analysis of
More informationGENE EXPRESSION REAGENTS MARKETS (SAMPLE COPY, NOT FOR RESALE)
TriMark Publications April 2007 Volume: TMRGER07-0401 GENE EXPRESSION REAGENTS MARKETS (SAMPLE COPY, NOT FOR RESALE) Trends, Industry Participants, Product Overviews and Market Drivers TABLE OF CONTENTS
More informationPOWER YOUR DIGITAL JOURNEY TO GREAT
www.hcltech.com HCL S DIGITAL AND ANALYTICS SERVICES POWER YOUR DIGITAL JOURNEY TO GREAT WX-3063 WHAT DOES DIGITAL MEAN TO YOU Is Digital a great website or an engaging App? Or is it a powerful, modular
More informationSmart India Hackathon
TM Persistent and Hackathons Smart India Hackathon 2017 i4c www.i4c.co.in Digital Transformation 25% of India between age of 16-25 Our country needs audacious digital transformation to reach its potential
More informationBig Data for the Pharmaceutical Industry
White Paper Big Data for the Pharmaceutical Industry Rapid Innovation by Reducing Data Management Overhead About Informatica Digital transformation changes expectations: better service, faster delivery,
More informationKonica Minolta and INCJ Agree to Acquire Ambry Genetics in a Deal Valued at US$1 billion
News Release Konica Minolta and INCJ Agree to Acquire Ambry Genetics in a Deal Valued at US$1 billion Advances Konica Minolta strategy to establish a leadership position in precision medicine Contributes
More informationHCL TeCHnoLogies AsseT MAnAgeMenT CApAbiLiTies implementation integration Co-innovATion
www.hcltech.com HCL Technologies Asset Management Capabilities Implementation Integration Co-Innovation The current market conditions and industry trends play an important role in defining the priorities
More informationDNA. bioinformatics. genomics. personalized. variation NGS. trio. custom. assembly gene. tumor-normal. de novo. structural variation indel.
DNA Sequencing T TM variation DNA amplicon mendelian trio genomics NGS bioinformatics tumor-normal custom SNP resequencing target validation de novo prediction personalized comparative genomics exome private
More informationPharmacogenetics: A SNPshot of the Future. Ani Khondkaryan Genomics, Bioinformatics, and Medicine Spring 2001
Pharmacogenetics: A SNPshot of the Future Ani Khondkaryan Genomics, Bioinformatics, and Medicine Spring 2001 1 I. What is pharmacogenetics? It is the study of how genetic variation affects drug response
More informationPersonalised Medicine Regulatory Issues
Personalised Medicine Regulatory Issues INFRAFRONTIER / IMPC Stakeholder Meeting Presented by Marisa Papaluca on 14 November 2017 Senior Scientific Advisor, Scientific Committees Regulatory Science Strategy
More informationHiTech Supply Chain Advisory Framework WHITE PAPER
HiTech Supply Chain Advisory Framework WHITE PAPER NOVEMBER 2012 TABLE OF CONTENTS INTRODUCTION 3 THE INDUSTRY ANALYSIS 4 THE METHODOLOGY 6 AUTHORS 12 ABOUT HCL 13 2 INTRODUCTION BACKGROUND AND OBJECTIVE
More informationLeveraging Social Media for Patient Insights in Pharmaceutical Industry. Narender Dureja, Shyam Chugh & Mannat Wadehra WHITE PAPER
Leveraging Social Media for Patient Insights in Pharmaceutical Industry Narender Dureja, Shyam Chugh & Mannat Wadehra WHITE PAPER JANUARY 2014 TABLE OF CONTENTS EXECUTIVE SUMMARY 3 CURRENT SCENARIO AND
More informationWELCOME. Norma J. Nowak, PhD Executive Director, NY State Center of Excellence in Bioinformatics and Life Sciences (CBLS)
WELCOME Norma J. Nowak, PhD Executive Director, NY State Center of Excellence in Bioinformatics and Life Sciences (CBLS) Director, UB Genomics and Bioinformatics Core (GBC) o o o o o o o o o o o o Grow
More informationThe NHS approach to personalised medicine in respiratory disease. Professor Sue Chief Scientific Officer for England
The NHS approach to personalised medicine in respiratory disease Professor Sue Hill @CSOSue Chief Scientific Officer for England Jul 2017 Genomics is probably the biggest breakthrough in the last 50 years.
More informationCapabilities & Services
Capabilities & Services Accelerating Research & Development Table of Contents Introduction to DHMRI 3 Services and Capabilites: Genomics 4 Proteomics & Protein Characterization 5 Metabolomics 6 In Vitro
More informationDNA. bioinformatics. epigenetics methylation structural variation. custom. assembly. gene. tumor-normal. mendelian. BS-seq. prediction.
Epigenomics T TM activation SNP target ncrna validation metagenomics genetics private RRBS-seq de novo trio RIP-seq exome mendelian comparative genomics DNA NGS ChIP-seq bioinformatics assembly tumor-normal
More informationSignal Integrity Analysis Using Statistical Methods
Signal Integrity Analysis Using Statistical Methods J u l y 2012 TABLE OF CONTENTS Abstract... 3 Abbreviations... 4 Introduction... 5 Why DOE?... 6 Signal Integrity Flow... 6 Case Study SATA Interface...
More informationAGILENT S BIOINFORMATICS ANALYSIS SOFTWARE
ACCELERATING PROGRESS IS IN OUR GENES AGILENT S BIOINFORMATICS ANALYSIS SOFTWARE GENESPRING GENE EXPRESSION (GX) MASS PROFILER PROFESSIONAL (MPP) PATHWAY ARCHITECT (PA) See Deeper. Reach Further. BIOINFORMATICS
More informationIntroduction to Bioinformatics
Introduction to Bioinformatics If the 19 th century was the century of chemistry and 20 th century was the century of physic, the 21 st century promises to be the century of biology...professor Dr. Satoru
More informationInformation Technology for Genetic and Genomic Based Personalized Medicine. Submitted. April 23, 2008
Information Technology for Genetic and Genomic Based Personalized Medicine Submitted April 23, 2008 By The Harvard Medical School Partners HealthCare Center for Genetics and Genomics in Partnership with
More informationILLUMINA SEQUENCING SYSTEMS
ILLUMINA SEQUENCING SYSTEMS PROVEN QUALITY. TRUSTED SOLUTIONS. Every day, researchers are using Illumina next-generation sequencing (NGS) systems to better understand human health and disease, as well
More informationIon S5 and Ion S5 XL Systems
Ion S5 and Ion S5 XL Systems Targeted sequencing has never been simpler Explore the Ion S5 and Ion S5 XL Systems Adopting next-generation sequencing (NGS) in your lab is now simpler than ever The Ion S5
More informationbig data & business analytics Unleash the power of real-time insights With HCL s Next Gen BI solution
big data & business analytics Unleash the power of real-time insights With HCL s Next Gen BI solution Bi not running at the speed of business? Are your senior managers frustrated with the amount of time
More informationPersonalized. Health in Canada
Personalized Health in Canada Canadian Institutes of Health Research Personalized Medicine Signature Initiative 2010-2013 0 Dr. Morag Park CIHR Institute of Cancer Research Dr. Paul Lasko CIHR Institute
More informationUS Food and Drug Administration. Sandra L. Kweder, MD Deputy Director, Europe Office
US Food and Drug Administration Sandra L. Kweder, MD Deputy Director, Europe Office Basics Disclaimer The views in this presentation are my own I have no commercial involvement in any of these activities
More information- OMICS IN PERSONALISED MEDICINE
SUMMARY REPORT - OMICS IN PERSONALISED MEDICINE Workshop to explore the role of -omics in the development of personalised medicine European Commission, DG Research - Brussels, 29-30 April 2010 Page 2 Summary
More informationTABLE OF CONTENTS. Introduction 3. Market Trends, Potential & Opportunity 3. Challenges in Today s Merchandising Landscape 4
JULY 2012 TABLE OF CONTENTS Introduction 3 Market Trends, Potential & Opportunity 3 Challenges in Today s Merchandising Landscape 4 Business Transformation Approach for 5 Modern Merchandising Integrated
More informationOutline. Genomics Medicine: Managing your own health. - Market overview: now and future. - What is genomic medicine?
Genomics Medicine: Managing your own health Mostafa Ronaghi SVP & CTO, Illumina Barcelona June 2013 2012 Illumina, Inc. All rights reserved. Illumina, illuminadx, BaseSpace, BeadArray, BeadXpress, cbot,
More informationThe Pragmatic Evolution of Automation Part of the Next Gen IT Whitepaper Series by HCL Technologies
www.hcltech.com The Pragmatic Evolution of Automation Part of the Next Gen IT Whitepaper Series by HCL Technologies WHITEPAPER OCTOBER 2016 TABLE OF CONTENTS INTRODUCTION: CHALLENGES OF THE DIGITAL ECONOMY
More informationLARGE DATA AND BIOMEDICAL COMPUTATIONAL PIPELINES FOR COMPLEX DISEASES
1 LARGE DATA AND BIOMEDICAL COMPUTATIONAL PIPELINES FOR COMPLEX DISEASES Ezekiel Adebiyi, PhD Professor and Head, Covenant University Bioinformatics Research and CU NIH H3AbioNet node Covenant University,
More informationGenoLogics LIMS Helps EdgeBio Build Services Business
LIMS Supports ResEarch & clinical NGS services LAB GenoLogics LIMS Helps EdgeBio Build Services Business LIMS Supports Research & Clinical NGS Services LAB GenoLogics LIMS Helps EdgeBio Build Services
More informationSTRAND NGS 3.0 ALLOWS USERS TO ANALYZE DATA AT NEARLY TWICE THE SPEED
bio chat STRAND NGS 3.0 ALLOWS USERS TO ANALYZE DATA AT NEARLY TWICE THE SPEED The Bangalore based Strand Life Sciences has been recently in news for the back to back launch of two innovative products.
More informationTotal genomic solutions for biobanks. Maximizing the value of your specimens.
Total genomic solutions for biobanks. Maximizing the value of your specimens. Unlock the true potential of your biological samples. Greater understanding. Increased value. Value-driven biobanking. Now
More informationACCELERATE BUSINESS VALUE WITH SAP INSTANCE CONSOLIDATION
ACCELERATE BUSINESS VALUE WITH SAP INSTANCE CONSOLIDATION THE AVERAGE OPERATIONAL COSTS OF RUNNING A SINGLE INSTANCE OF SAP ARE 25 40% LOWER THAN RUNNING MULTIPLE INSTANCES THE FUTURE OF SAP RESEARCH,
More informationIon S5 and Ion S5 XL Systems
Ion S5 and Ion S5 XL Systems Targeted sequencing has never been simpler Explore the Ion S5 and Ion S5 XL Systems Adopting next-generation sequencing (NGS) in your lab is now simpler than ever The Ion S5
More informationCASE STUDY: INVESTMENT MANAGEMENT FIRM TRANSFORMS PORTFOLIO MANAGEMENT TO MAKE TRADING DECISIONS IN REAL TIME
CASE STUDY: INVESTMENT MANAGEMENT FIRM TRANSFORMS PORTFOLIO MANAGEMENT TO MAKE TRADING DECISIONS IN REAL TIME INTRODUCTION A leading investment management firm dedicated to evidence-based investing in
More informationWhole Genome Sequencing in Cancer Diagnostics (research) Nederlandse Pathologiedagen 19 & 20 November 2015
Whole Genome Sequencing in Cancer Diagnostics (research) Nederlandse Pathologiedagen 19 & 20 November 2015 Dr. I.J. Nijman Disclosure slide (Potential) conflict of interest None For this meeting relevant
More informationJanus Clinical Trials Repository: Modernizing the Review Process through Innovation
Janus Clinical Trials Repository: Modernizing the Review Process through Innovation Lilliam Rosario, Ph.D. Director Office of Computational Science Food and Drug Administration Janus Clinical Trials Repository
More informationFollowing text taken from Suresh Kumar. Bioinformatics Web - Comprehensive educational resource on Bioinformatics. 6th May.2005
Bioinformatics is the recording, annotation, storage, analysis, and searching/retrieval of nucleic acid sequence (genes and RNAs), protein sequence and structural information. This includes databases of
More informationArtificial Intelligence in Life Sciences: The Formula for Pharma Success Across the Drug Lifecycle
Volume XX, Issue 60 Artificial Intelligence in Life Sciences: The Formula for Pharma Success Across the Drug Lifecycle Artificial intelligence (AI) has the potential to transform the pharmaceutical industry.
More informationCRO partner in Rx/CDx Co-Development
CRO partner in Rx/CDx Co-Development DEDICATED DIALOGUE A sponsored roundtable discussion published in Pharmaceutical Executive Two Covance executives discuss a CRO s role in supporting Companion Diagnostics
More informationSubmission to House of Lords Science and Technology Select Committee Oxford Nanopore Technologies Ltd April 2008
(Previously Oxford NanoLabs) Genomic Medicine Submission to House of Lords Science and Technology Select Committee Oxford Nanopore Technologies Ltd April 2008 Introduction Oxford Nanopore Technologies
More informationThe Need for Scientific. Data Annotation. Alick K Law, Ph.D., M.B.A. Marketing Manager IBM Life Sciences.
The Need for Scientific Data Annotation Alick K Law, Ph.D., M.B.A. Marketing Manager IBM Life Sciences alaw@us.ibm.com Cross disciplinary research approach requires organizations to address diverse needs
More informationJefferies Healthcare Conference. Frank Witney, President & CEO
Jefferies Healthcare Conference Frank Witney, President & CEO Forward Looking Statement This presentation contains statements that are "forward-looking statements" within the meaning of the Securities
More informationresequencing storage SNP ncrna metagenomics private trio de novo exome ncrna RNA DNA bioinformatics RNA-seq comparative genomics
RNA Sequencing T TM variation genetics validation SNP ncrna metagenomics private trio de novo exome mendelian ChIP-seq RNA DNA bioinformatics custom target high-throughput resequencing storage ncrna comparative
More informationACCELERATING GENOMIC ANALYSIS ON THE CLOUD. Enabling the PanCancer Analysis of Whole Genomes (PCAWG) consortia to analyze thousands of genomes
ACCELERATING GENOMIC ANALYSIS ON THE CLOUD Enabling the PanCancer Analysis of Whole Genomes (PCAWG) consortia to analyze thousands of genomes Enabling the PanCancer Analysis of Whole Genomes (PCAWG) consortia
More informationSupply Chain Visibility Roadmap. Author Ranjan Arora WHITE PAPER
Supply Chain Visibility Roadmap Author Ranjan Arora WHITE PAPER JULY 2012 TABLE OF CONTENTS Abstract 3 Supply Chain Visibility: Definition and Key Trends 3 SCV Framework: The Need 4 Supply Chain Visibility:
More informationIT Risk Advisory & Management Services
IT Advisory & Management Services The (Ever) Evolving IT Management Organizations today, view IT risk management as a necessity. As a consequence, organizations need to realign their IT risk management
More informationGenomes contain all of the information needed for an organism to grow and survive.
Section 3: Genomes contain all of the information needed for an organism to grow and survive. K What I Know W What I Want to Find Out L What I Learned Essential Questions What are the components of the
More informationDemystify Governance, Risk & Compliance For Lifesciences
www.hcltech.com Demystify Governance, Risk & Compliance For Lifesciences Competitive global markets, more-demanding patients, regulations from multiple regulatory authorities and high product development
More informationPolicy Administration Transformation
Financial Services the way we do it Policy Administration Transformation Helping insurers capture dramatic improvements in time-to-market, product or price leadership and operational excellence The insurance
More information2018 North American Real-World Evidence Enterprise Solutions Market Leadership Award
2018 North American Real-World Evidence Enterprise Solutions Market Leadership Award 2018 2018 NORTH AMERICAN REAL-WORLD EVIDENCE ENTERPRISE SOLUTIONS MARKET LEADERSHIP AWARD Contents Background and Company
More informationNext Generation Sequencing (NGS) Market Size, Growth and Trends ( )
Next Generation Sequencing (NGS) Market Size, Growth and Trends (2014-2020) July, 2017 4 th edition Information contained in this market report is believed to be reliable at the time of publication. DeciBio
More informationClinical Data in Business Intelligence
Paper DV07 Clinical Data in Business Intelligence Mike Collinson, Oracle Heath Sciences Consulting (HSC), Reading, UK ABSTRACT Clinical organizations are under increasing pressure to execute clinical trials
More informationReads to Discovery. Visualize Annotate Discover. Small DNA-Seq ChIP-Seq Methyl-Seq. MeDIP-Seq. RNA-Seq. RNA-Seq.
Reads to Discovery RNA-Seq Small DNA-Seq ChIP-Seq Methyl-Seq RNA-Seq MeDIP-Seq www.strand-ngs.com Analyze Visualize Annotate Discover Data Import Alignment Vendor Platforms: Illumina Ion Torrent Roche
More informationAKESOgen, Inc, 3155 Northwoods Place, NW, Norcross, GA 30071, USA Tel: +1 (770) Page 1
Page 1 HLA Sequencing Based Typing Workflow: A- Sample Collection: iswab-discovery (Mawi DNA Technologies) - Sample was transported by standard US postal services mail, no cold chain of any sort was involved
More informationAccelerating Precision Medicine with High Performance Computing Clusters
Accelerating Precision Medicine with High Performance Computing Clusters Scalable, Standards-Based Technology Fuels a Big Data Turning Point in Genome Sequencing Executive Summary Healthcare is in worldwide
More information